rs149290511
Variant names:
Variant summary
Our verdict is Benign. The variant received -16 ACMG points: 0P and 16B. BP4_StrongBP6_Very_StrongBS1
The NM_139343.3(BIN1):c.1003-15G>A variant causes a intron change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.000226 in 1,508,376 control chromosomes in the GnomAD database, including 1 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Likely benign (★★).
Frequency
Genomes: 𝑓 0.00094 ( 1 hom., cov: 32)
Exomes 𝑓: 0.00015 ( 0 hom. )
Consequence
BIN1
NM_139343.3 intron
NM_139343.3 intron
Scores
2
Clinical Significance
Conservation
PhyloP100: 0.823
Publications
0 publications found
Genes affected
BIN1 (HGNC:1052): (bridging integrator 1) This gene encodes several isoforms of a nucleocytoplasmic adaptor protein, one of which was initially identified as a MYC-interacting protein with features of a tumor suppressor. Isoforms that are expressed in the central nervous system may be involved in synaptic vesicle endocytosis and may interact with dynamin, synaptojanin, endophilin, and clathrin. Isoforms that are expressed in muscle and ubiquitously expressed isoforms localize to the cytoplasm and nucleus and activate a caspase-independent apoptotic process. Studies in mouse suggest that this gene plays an important role in cardiac muscle development. Alternate splicing of the gene results in several transcript variants encoding different isoforms. Aberrant splice variants expressed in tumor cell lines have also been described. [provided by RefSeq, Mar 2016]
BIN1 Gene-Disease associations (from GenCC):
- myopathy, centronuclear, 2Inheritance: AR Classification: DEFINITIVE, STRONG, MODERATE Submitted by: G2P, Labcorp Genetics (formerly Invitae), Ambry Genetics
- centronuclear myopathyInheritance: SD Classification: DEFINITIVE Submitted by: ClinGen
- autosomal dominant centronuclear myopathyInheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet
- autosomal recessive centronuclear myopathyInheritance: AR Classification: SUPPORTIVE Submitted by: Orphanet
Genome browser will be placed here
ACMG classification
Classification was made for transcript
Our verdict: Benign. The variant received -16 ACMG points.
BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.63).
BP6
Variant 2-127057616-C-T is Benign according to our data. Variant chr2-127057616-C-T is described in ClinVar as Benign/Likely_benign. ClinVar VariationId is 262470.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BS1
Variant frequency is greater than expected in population afr. GnomAd4 allele frequency = 0.000942 (143/151844) while in subpopulation AFR AF = 0.00331 (137/41390). AF 95% confidence interval is 0.00286. There are 1 homozygotes in GnomAd4. There are 67 alleles in the male GnomAd4 subpopulation. Median coverage is 32. This position passed quality control check.
Transcripts
RefSeq
| Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | MANE | Protein | UniProt |
|---|---|---|---|---|---|---|---|---|
| BIN1 | NM_139343.3 | c.1003-15G>A | intron_variant | Intron 11 of 18 | ENST00000316724.10 | NP_647593.1 |
Ensembl
Frequencies
GnomAD3 genomes AF: 0.000929 AC: 141AN: 151726Hom.: 1 Cov.: 32 show subpopulations
GnomAD3 genomes
AF:
AC:
141
AN:
151726
Hom.:
Cov.:
32
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD2 exomes AF: 0.000375 AC: 49AN: 130824 AF XY: 0.000265 show subpopulations
GnomAD2 exomes
AF:
AC:
49
AN:
130824
AF XY:
Gnomad AFR exome
AF:
Gnomad AMR exome
AF:
Gnomad ASJ exome
AF:
Gnomad EAS exome
AF:
Gnomad FIN exome
AF:
Gnomad NFE exome
AF:
Gnomad OTH exome
AF:
GnomAD4 exome AF: 0.000146 AC: 198AN: 1356532Hom.: 0 Cov.: 30 AF XY: 0.000146 AC XY: 97AN XY: 663504 show subpopulations
GnomAD4 exome
AF:
AC:
198
AN:
1356532
Hom.:
Cov.:
30
AF XY:
AC XY:
97
AN XY:
663504
show subpopulations
African (AFR)
AF:
AC:
129
AN:
30544
American (AMR)
AF:
AC:
18
AN:
31782
Ashkenazi Jewish (ASJ)
AF:
AC:
0
AN:
23460
East Asian (EAS)
AF:
AC:
2
AN:
34854
South Asian (SAS)
AF:
AC:
2
AN:
74288
European-Finnish (FIN)
AF:
AC:
0
AN:
47660
Middle Eastern (MID)
AF:
AC:
9
AN:
4366
European-Non Finnish (NFE)
AF:
AC:
23
AN:
1053556
Other (OTH)
AF:
AC:
15
AN:
56022
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.509
Heterozygous variant carriers
0
11
21
32
42
53
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance
Age Distribution
Exome Het
Variant carriers
0
10
20
30
40
50
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome AF: 0.000942 AC: 143AN: 151844Hom.: 1 Cov.: 32 AF XY: 0.000903 AC XY: 67AN XY: 74186 show subpopulations
GnomAD4 genome
AF:
AC:
143
AN:
151844
Hom.:
Cov.:
32
AF XY:
AC XY:
67
AN XY:
74186
show subpopulations
African (AFR)
AF:
AC:
137
AN:
41390
American (AMR)
AF:
AC:
3
AN:
15252
Ashkenazi Jewish (ASJ)
AF:
AC:
0
AN:
3468
East Asian (EAS)
AF:
AC:
0
AN:
5142
South Asian (SAS)
AF:
AC:
0
AN:
4786
European-Finnish (FIN)
AF:
AC:
0
AN:
10566
Middle Eastern (MID)
AF:
AC:
1
AN:
294
European-Non Finnish (NFE)
AF:
AC:
2
AN:
67938
Other (OTH)
AF:
AC:
0
AN:
2098
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.488
Heterozygous variant carriers
0
7
13
20
26
33
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance
Age Distribution
Genome Het
Variant carriers
0
2
4
6
8
10
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
Hom.:
Bravo
AF:
Asia WGS
AF:
AC:
4
AN:
3478
ClinVar
Significance: Benign/Likely benign
Submissions summary: Benign:3
Revision: criteria provided, multiple submitters, no conflicts
LINK: link
Submissions by phenotype
not specified Benign:1
-
PreventionGenetics, part of Exact Sciences
Significance:Likely benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing
- -
not provided Benign:1
-
Breakthrough Genomics, Breakthrough Genomics
Significance:Likely benign
Review Status:criteria provided, single submitter
Collection Method:not provided
- -
Myopathy, centronuclear, 2 Benign:1
Nov 27, 2024
Labcorp Genetics (formerly Invitae), Labcorp
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing
- -
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
DANN
Benign
PhyloP100
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at
Publications
You must be logged in to view publications. This limit was set because tens of millions (!) of queries from AI bots are generated daily.